BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31832909)

  • 1. Phillyrin Relieves Lipopolysaccharide-Induced AKI by Protecting Against Glycocalyx Damage and Inhibiting Inflammatory Responses.
    Zhang D; Qi B; Li D; Feng J; Huang X; Ma X; Huang L; Wang X; Liu X
    Inflammation; 2020 Apr; 43(2):540-551. PubMed ID: 31832909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
    Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
    Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS.
    Wang L; Huang X; Kong G; Xu H; Li J; Hao D; Wang T; Han S; Han C; Sun Y; Liu X; Wang X
    Biochem Biophys Res Commun; 2016 Sep; 478(2):669-75. PubMed ID: 27498004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS.
    Huang L; Zhang X; Ma X; Zhang D; Li D; Feng J; Pan X; Lü J; Wang X; Liu X
    Int Immunopharmacol; 2018 Dec; 65():96-107. PubMed ID: 30308440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crocin alleviates lipopolysaccharide-induced acute respiratory distress syndrome by protecting against glycocalyx damage and suppressing inflammatory signaling pathways.
    Zhang D; Qi BY; Zhu WW; Huang X; Wang XZ
    Inflamm Res; 2020 Mar; 69(3):267-278. PubMed ID: 31925528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide-induced pulmonary endothelial glycocalyx loss via ALX/SIRT1/NF-kappa B axis.
    Wang XY; Li XY; Wu CH; Hao Y; Fu PH; Mei HX; Chen F; Gong YQ; Jin SW; Li H
    Respir Res; 2021 Jul; 22(1):193. PubMed ID: 34217286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx.
    Li H; Hao Y; Yang LL; Wang XY; Li XY; Bhandari S; Han J; Liu YJ; Gong YQ; Scott A; Smith FG; Jin SW
    J Cell Physiol; 2020 Oct; 235(10):7283-7294. PubMed ID: 32037554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
    Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
    Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nephroprotective Effect of MS-275 on Lipopolysaccharide (LPS)-Induced Acute Kidney Injury by Inhibiting Reactive Oxygen Species (ROS)-Oxidative Stress and Endoplasmic Reticulum Stress.
    Zhang H; Zhang W; Jiao F; Li X; Zhang H; Wang L; Gong Z
    Med Sci Monit; 2018 Apr; 24():2620-2630. PubMed ID: 29704392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice.
    Huang X; Kong G; Li Y; Zhu W; Xu H; Zhang X; Li J; Wang L; Zhang Z; Wu Y; Liu X; Wang X
    Biomed Pharmacother; 2016 Dec; 84():447-453. PubMed ID: 27685787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
    Kiyonaga N; Moriyama T; Kanmura Y
    Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx.
    Kong G; Huang X; Wang L; Li Y; Sun T; Han S; Zhu W; Ma M; Xu H; Li J; Zhang X; Liu X; Wang X
    Int Immunopharmacol; 2016 Jul; 36():51-58. PubMed ID: 27111514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation.
    Hu J; Liu J
    Inflammation; 2016 Apr; 39(2):569-74. PubMed ID: 26552405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation.
    Hui D; Rui-Zhi T; Jian-Chun L; Xia Z; Dan W; Jun-Ming F; Li W
    J Ethnopharmacol; 2020 Apr; 252():112637. PubMed ID: 32004631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol Extract of
    Islam MS; Miao L; Yu H; Han Z; Sun H
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway.
    Fu H; Hu Z; Di X; Zhang Q; Zhou R; Du H
    Eur J Pharmacol; 2016 Nov; 791():229-234. PubMed ID: 27546562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidanpaidu prescription alleviates lipopolysaccharide-induced acute kidney injury by suppressing the NF-κB signaling pathway.
    Zhang F; Lu S; Jin S; Chen K; Li J; Huang B; Cao Y
    Biomed Pharmacother; 2018 Mar; 99():245-252. PubMed ID: 29334668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin Alleviates IRI-Induced Kidney Injury by Inhibiting Inflammatory Response of Macrophages via AKT-Related Pathways.
    Yan Y; Tan RZ; Liu P; Li JC; Zhong X; Liao Y; Lin X; Wei C; Wang L
    Med Sci Monit; 2020 May; 26():e921114. PubMed ID: 32362652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HYAL1 deficiency attenuates lipopolysaccharide-triggered renal injury and endothelial glycocalyx breakdown in septic AKI in mice.
    Xing H; Li S; Fu Y; Wan X; Zhou A; Cao F; Sun Q; Hu N; Ma M; Li W; Cao C
    Ren Fail; 2023 Dec; 45(1):2188966. PubMed ID: 37563795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation.
    Li J; Wang L; Wang B; Zhang Z; Jiang L; Qin Z; Zhao Y; Su B
    Theranostics; 2023; 13(9):2863-2878. PubMed ID: 37284448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.